drugset / Trial / NCT06713785
Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension
Phase 4
Withdrawn
Queen Mary University of London
Closed Loop Medicine Ltd · collabInnovate UK · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective of the study is to assess precision dosing of amlodipine to deliver reductions in blood pressure in patients with primary hypertension and inadequate BP control by up-titration of amlodipine in 1mg increments
Timeline
- Start
- 2020-09-26
- Primary completion
- 2021-01-31
- Completion
- 2021-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 10 mg | Oral |